Despite the low uptake by M1 macrophages, MP regulated inflammation, and induced the expression of tumor inhibitory cytokines IL1-β and TNFα (34–36), indicating that M1 macrophages may be a potential target for MP therapy in inflammatory diseases and cancer. Here, IL1B is linked to cancer.